Ohno S, Natsu-ume-Sakai S, Migita S
J Natl Cancer Inst. 1977 Feb;58(2):229-37. doi: 10.1093/jnci/58.2.229.
The correlation between the changes of immunoglobulin synthesis and the surface antigenicity was analyzed by cytotoxicity and quantitative antibody-absorption tests with the cells of immunoglobulin-producing and nonproducing mouse plasmacytoma. IgA-synthesizing BLAB/c plasmacytoma 58-8 and the non-IgA-synthesizing variant of the 58-8 (nonproducer) were killed with rabbit anti-58-8 plasmacytoma cell antiserum, C3H/He anti-BALB/c spleen cell antiserum, and (C57BL/6 X DBA/2)F1 anti-BALB/c plasmacytoma cell MOPC-31C antiserum plus complement, only when the cells were pretreated with pronase. Quantitative absorption tests revealed that the nonproducer, 58-8 had the same amount of plasmacytoma antigen of 58-8 and PC.1 antigen, and a greater amount of H-2d antigen, as did producer 58-8. The same analysis was carried out for the C3H mouse plasmacytoma X5563, which has an M-component of IgG2a. The nonproducer X5563 had a greater amount of H-2k antigen and a smaller amount of the plasmacytoma antigen of X5563 than did the producer X5563. No detectable PC.1 antigen was observed at surfaces of the producer and the nonproducer X5563 cells.
通过细胞毒性试验以及针对产生免疫球蛋白和不产生免疫球蛋白的小鼠浆细胞瘤细胞的定量抗体吸收试验,分析了免疫球蛋白合成变化与表面抗原性之间的相关性。用兔抗58-8浆细胞瘤细胞抗血清、C3H/He抗BALB/c脾细胞抗血清以及(C57BL/6×DBA/2)F1抗BALB/c浆细胞瘤细胞MOPC-31C抗血清加补体对产生IgA的BLAB/c浆细胞瘤58-8及其58-8的不产生IgA的变体(不产生者)进行杀伤,只有当细胞用链霉蛋白酶预处理时才能实现。定量吸收试验显示,不产生者58-8与产生者58-8一样,具有相同数量的58-8浆细胞瘤抗原和PC.1抗原,以及更多数量的H-2d抗原。对具有IgG2a M成分的C3H小鼠浆细胞瘤X5563进行了同样的分析。不产生者X5563比产生者X5563具有更多数量的H-2k抗原和更少数量的X5563浆细胞瘤抗原。在产生者和不产生者X5563细胞表面均未观察到可检测到的PC.1抗原。